BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
dr.agarwals eye hospital ltd. stock

DR.AGARWALS EYE HOSPITAL LTD. Share Price

5600 143.00 (2.62%)
Dec 13 2024 03:29 PM Healthcare NSE: DRAGARWQ

DR.AGARWALS EYE HOSPITAL LTD. Share Price Update

As of the latest trading session, DR.AGARWALS EYE HOSPITAL LTD. share price is currently at 5600, which is up by 143.00 from its previous closing. Today, the stock has fluctuated between 5450.05 and 5645.00. Over the past year, DR.AGARWALS EYE HOSPITAL LTD. has achieved a return of 106.82 %. In the last month alone, the return has been 17.35 %. Read More...

DR.AGARWALS EYE HOSPITAL LTD. Performance

Day Range

Low5450.05 High5645.00
5605.00

52 Week Range

Low 2541.80 High 5759.00
5605.00

DR.AGARWALS EYE HOSPITAL LTD. Share Price

526783

DRAGARWQ

img img img img
No Data Available

Open Price

5538.00

Prev. Close

5457.00

Volume (Shares)

613.00

Total traded value

34.06

Upper Circuit

6548.40

Lower Circuit

4365.60

Note: The current prices & values are delayed, Login to your account for live updates.

DR.AGARWALS EYE HOSPITAL LTD. Fundamentals


(Standalone)

Market Cap (Cr) 2634.40
PE Ratio (TTM) 52.17
Book Value / Share 391.57
Beta 0.25
ROE 34.28%
EPS (TTM) 107.43
Dividend Yield 0.04%
Net Profit Qtr (Cr) 14.15

DR.AGARWALS EYE HOSPITAL LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 102.19
Operating Expense 85.34
Net Profit 14.15
Net Profit Margin (%) 13.84
Earnings Per Share (EPS) 30.11
EBITDA 32.16
Effective Tax Rate (%) 26.03
Particulars JUN 2024 (Values in Cr)
Revenue 100.02
Operating Expense 81.51
Net Profit 14.11
Net Profit Margin (%) 14.10
Earnings Per Share (EPS) 30.02
EBITDA 31.81
Effective Tax Rate (%) 25.38
Particulars MAR 2024 (Values in Cr)
Revenue 80.72
Operating Expense 65.84
Net Profit 12.79
Net Profit Margin (%) 15.84
Earnings Per Share (EPS) 27.21
EBITDA 26.90
Effective Tax Rate (%) 26.23
Particulars DEC 2023 (Values in Cr)
Revenue 75.95
Operating Expense 63.90
Net Profit 9.44
Net Profit Margin (%) 12.42
Earnings Per Share (EPS) 20.09
EBITDA 21.44
Effective Tax Rate (%) 25.78
Particulars SEP 2023 (Values in Cr)
Revenue 84.09
Operating Expense 68.91
Net Profit 12.59
Net Profit Margin (%) 14.97
Earnings Per Share (EPS) 26.79
EBITDA 24.68
Effective Tax Rate (%) 24.38
Particulars MAR 2024 (Values in Cr)
Revenue 319.30
Operating Expense 262.02
Net Profit 46.36
Net Profit Margin (%) 14.51
Earnings Per Share (EPS) 98.64
EBITDA 96.03
Effective Tax Rate (%) 25.52
Particulars MAR 2023 (Values in Cr)
Revenue 268.10
Operating Expense 220.25
Net Profit 36.92
Net Profit Margin (%) 13.77
Earnings Per Share (EPS) 78.55
EBITDA 76.44
Effective Tax Rate (%) 25.26
Particulars MAR 2022 (Values in Cr)
Revenue 201.21
Operating Expense 170.16
Net Profit 24.10
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 51.29
EBITDA 58.93
Effective Tax Rate (%) 25.41
Particulars MAR 2021 (Values in Cr)
Revenue 139.81
Operating Expense 134.89
Net Profit -1.44
Net Profit Margin (%) -1.02
Earnings Per Share (EPS) -3.06
EBITDA 31.18
Effective Tax Rate (%) 125.13
Particulars MAR 2020 (Values in Cr)
Revenue 175.95
Operating Expense 158.66
Net Profit 13.68
Net Profit Margin (%) 7.77
Earnings Per Share (EPS) 29.11
EBITDA 48.89
Effective Tax Rate (%) 31.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 334.36
ROE % 34.28
ROCE % 17.89
Total Debt to Total Equity 1.85
EBITDA Margin 30.43
Particulars MAR 2023 (Values in Cr)
Book Value / Share 241.15
ROE % 38.56
ROCE % 18.22
Total Debt to Total Equity 2.22
EBITDA Margin 28.95
Particulars MAR 2022 (Values in Cr)
Book Value / Share 166.32
ROE % 36.29
ROCE % 19.63
Total Debt to Total Equity 1.96
EBITDA Margin 29.77
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.30
ROE % -2.60
ROCE % 10.36
Total Debt to Total Equity 1.15
EBITDA Margin 22.74
Particulars MAR 2020 (Values in Cr)
Book Value / Share 119.36
ROE % 26.91
ROCE % 29.26
Total Debt to Total Equity 0.82
EBITDA Margin 28.29
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 33.74
Total Assets 495.76
Total Liabilities 495.76
Total Equity 157.15
Share Outstanding 4700000
Price to Book Ratio 9.28
Return on Assets (%) 9.35
Return on Capital (%) 22.24
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.10
Total Assets 389.94
Total Liabilities 389.94
Total Equity 113.34
Share Outstanding 4700000
Price to Book Ratio 3.80
Return on Assets (%) 9.46
Return on Capital (%) 23.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.80
Total Assets 314.01
Total Liabilities 314.01
Total Equity 78.17
Share Outstanding 4700000
Price to Book Ratio 4.39
Return on Assets (%) 7.67
Return on Capital (%) 21.89
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 22.19
Total Assets 155.23
Total Liabilities 155.23
Total Equity 54.66
Share Outstanding 4700000
Price to Book Ratio 2.69
Return on Assets (%) -0.92
Return on Capital (%) -1.89
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.88
Total Assets 140.55
Total Liabilities 140.55
Total Equity 56.10
Share Outstanding 4700000
Price to Book Ratio 1.60
Return on Assets (%) 9.73
Return on Capital (%) 19.73
Particulars MAR 2024 (Values in Cr)
Net Income 62.25
Cash from Operations 103.38
Cash from Investing -70.04
Cash from Financing -14.23
Net change in Cash 5.50
Free Cash Flow 174.69
Particulars MAR 2023 (Values in Cr)
Net Income 49.40
Cash from Operations 81.14
Cash from Investing -70.61
Cash from Financing 0.26
Net change in Cash -0.73
Free Cash Flow 151.48
Particulars MAR 2022 (Values in Cr)
Net Income 24.10
Cash from Operations 65.61
Cash from Investing -46.28
Cash from Financing -3.81
Net change in Cash 6.59
Free Cash Flow 112.34
Particulars MAR 2021 (Values in Cr)
Net Income -1.43
Cash from Operations 37.19
Cash from Investing -10.96
Cash from Financing -7.59
Net change in Cash 15.30
Free Cash Flow 48.38
Particulars MAR 2020 (Values in Cr)
Net Income 13.68
Cash from Operations 45.36
Cash from Investing -16.67
Cash from Financing -19.93
Net change in Cash 2.00
Free Cash Flow 62.49
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.05 0.00 3.89 116.29 44.00 / 107.94
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
VIMTA LABS LIMITED 956.50 39.79 6.19 2124.70 390.60 / 981.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 5590.20
  • 26 Days 5328.10
  • 10 Days 5502.50
  • 50 Days 5212.10
  • 12 Days 5454.60
  • 100 Days 4726.30
  • 20 Days 5315.30
  • 200 Days 3490.50
5496.02
PIVOT
First Resistance 5560.98
Second Resistance 5664.97
Third Resistance 5729.93
First Support 5392.03
Second Support 5327.07
Third Support 5223.08
RSI 62.52
MACD 126.57
Commodity Channel Index (CCI) 82.78
ADX 27.03
Williams % R -19.26

Over 1 Month

down

17.35

Over 3 Months

down

37.23

Over 6 Months

down

78.85

Over 1 Year

down

106.82

Over 3 Years

down

88.81

Over 5 Years

down

83.36

DR.AGARWALS EYE HOSPITAL LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

DR.AGARWALS EYE HOSPITAL LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
27.45
Promoter Holdings
71.89
FII
0.64
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Dr. Agarwal's Health Care Limited Shareholding of Promoter and Promoter Group 3379098.0 71.9
Varun Ashok Hiremath Public Shareholding 75985.0 1.62
Pankaj Sondhi Shareholding of Promoter and Promoter Group 0.0 0.0
Dr. Athiya Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Dr. Anosh Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Dr. Amar Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Dr. Adil Agarwal Shareholding of Promoter and Promoter Group 0.0 0.0
Dr. Ashvin Agarwal Shareholding of Promoter and Promoter Group 5.0 0.0
Dr. Ashar Agarwal Shareholding of Promoter and Promoter Group 5.0 0.0
Dr. Sunita Agarwal Shareholding of Promoter and Promoter Group 63.0 0.0

DR.AGARWALS EYE HOSPITAL LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-10-31 2.5 Interim 2023-10-31 Equity shares 2023-09-14 3.0 Final 2023-09-15 Equity shares 2022-09-06 3.0 Final 2022-09-08 Equity shares 2019-09-16 1.5 Final 2019-09-18 Equity shares 2018-08-21 1.2 Final 2018-08-24 Equity shares 2017-08-14 1.5 Final 2017-08-17 Equity shares 2016-08-12 0.8 Final 2016-08-17 Equity shares 2015-09-01 1.2 Final 2015-09-03 Equity shares 2014-08-28 1.2 Final 2014-09-02 Equity shares 2013-08-02 1.2 Final 2013-08-06 Equity shares 2011-08-11 1.2 Final 2011-08-16 Equity shares 2010-08-13 0.8 Final 2010-08-17 Equity shares 2007-09-13 1.5 Final 2007-09-15 Equity shares 2005-09-12 0.0 Final 2005-09-14 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About DR.AGARWALS EYE HOSPITAL LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by DR.AGARWALS EYE HOSPITAL LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Dr Agarwals Eye Hospital Ltd?

Answer Field

The share price of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 0.00 and for BSE is ₹ 5605.00.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd?

Answer Field

The market cap of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 26,34.40 Cr. as of now.

What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd?

Answer Field

The 52 Week High and Low of Dr Agarwals Eye Hospital Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 5759.00 and ₹ 2541.80.

How to Buy Dr Agarwals Eye Hospital Ltd share?

Answer Field

You can trade in Dr Agarwals Eye Hospital Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Dr Agarwals Eye Hospital Ltd?

Answer Field

The 1 year returns on the stock has been 106.82%.

What is the Current Share Price of Dr Agarwals Eye Hospital Ltd?

Answer Field

Dr Agarwals Eye Hospital Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 5605.00 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

The market cap of Dr Agarwals Eye Hospital Ltd for NSE ₹ 0.0 & for BSE ₹ 26,34.40 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Dr Agarwals Eye Hospital Ltd share is 52.17.

What is the PB ratio of Dr Agarwals Eye Hospital Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Dr Agarwals Eye Hospital Ltd share is 391.57.

How to Buy Dr Agarwals Eye Hospital Ltd Share?

Answer Field

You can trade in Dr Agarwals Eye Hospital Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Dr Agarwals Eye Hospital Ltd Share on Bajaj Broking App?

Answer Field

To buy Dr Agarwals Eye Hospital Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Dr Agarwals Eye Hospital Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader